Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Diseases
85%
Neoplasm
66%
Nanoparticle
61%
Malignant Neoplasm
58%
Glucagon-Like Peptide-1
54%
Drug Delivery System
46%
Antiinfective Agent
44%
Receptor
38%
Non Insulin Dependent Diabetes Mellitus
36%
Infection
35%
Transdermal
33%
Gastric Inhibitory Polypeptide Receptor
32%
Diabetes Mellitus
31%
Transdermal Delivery
29%
Cross-Sectional Study
29%
Inflammation
28%
Side Effect
28%
SARS Coronavirus
28%
Exendin 4
26%
Photodynamic Therapy
25%
Incretin
24%
Pancreas Cancer
23%
Streptozotocin
23%
Ob/Ob Mouse
22%
Nanomaterial
21%
Drug Release
21%
Diabetic Obesity
20%
Antibiotics
19%
Pharmacotherapy
18%
Coronavirinae
18%
Hypoxia
17%
Pandemic
16%
Respiratory Tract Disease
16%
Combination Therapy
16%
Chemotherapy
16%
Glucagon-Like Peptide 1 Receptor
16%
Pharmacokinetics
15%
Prostate Cancer
15%
HIV
14%
Oxygenase
14%
Targeted Drug Delivery
14%
Glucagon
14%
Lung Cancer
14%
Breast Cancer
14%
Metformin
13%
Rose Bengal
13%
Clinical Pharmacy
13%
Photosensitizer
13%
Colon Carcinoma
13%
Community Pharmacy
13%
Antioxidant
13%
Macrogol
13%
Colitis
13%
Chronic Respiratory Tract Disease
13%
Amino Acid
12%
Antimicrobial Resistance
12%
Receptor Antagonist
12%
Biological Marker
12%
Prevalence
12%
Clinical Trial
12%
Aminolevulinic Acid
11%
Pharmacy Practice
11%
Cytotoxicity
11%
Nanocarrier
11%
Polymersome
11%
Liposome
11%
Polyglactin
11%
Antidiabetic Agent
11%
Macrogol Derivative
11%
Inflammatory Bowel Disease
11%
Tablet
11%
Cardiovascular Disease
11%
Oxyntomodulin
11%
Solid Malignant Neoplasm
10%
Peptide YY
10%
Nanomedicine
10%
Bioavailability
10%
Polyvinyl Alcohol
10%
Carboxamide
10%
Nucleic Acid
10%
Biological Activity
10%
Fibrosis
9%
Gemcitabine
9%
Wound
9%
Cholecystokinin
9%
Anti-Inflammatory Drug
9%
Receptor Agonist
9%
Insulin Dependent Diabetes Mellitus
9%
Cytokine
9%
Peptide Fragment
9%
Dipeptidyl Peptidase IV
9%
Biocompatibility
8%
Tumor Growth
8%
Ovalbumin
8%
Proteinase
8%
Cathepsin B
8%
Ibuprofen
8%
Cell Viability
8%
Plant Extract
8%
Medicine and Dentistry
Gastric Inhibitory Polypeptide
75%
Diabetes
68%
Beta Cell
45%
Receptor
43%
Glucagon Like Peptide 1
34%
Neoplasm
32%
Pancreatic Islet
27%
COVID-19
26%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
In Vitro
23%
Streptozocin
23%
Diseases
22%
Sonodynamic Therapy
21%
Maturity Onset Diabetes of the Young
19%
Cell Transdifferentiation
19%
Diabetes Mellitus
19%
Incretin
18%
Glucagon
17%
Glucose Tolerance
17%
Insulin Resistance
16%
Exenatide
16%
Infection
16%
High Fat Food
15%
Malignant Neoplasm
14%
Photochemotherapy
14%
Nanoparticle
13%
Pancreas Cancer
13%
Glucagon Like Peptide 1 Receptor
13%
Insulin Release
13%
Antiinfective Agent
12%
Cholecystokinin Octapeptide
12%
Gastrointestinal Hormone
12%
Diabetic Obesity
12%
Antidiabetic Activity
12%
Cell Survival
11%
Cell Function
11%
Prostate Cancer
11%
Bone Strength
11%
Body Weight
11%
Programmed Cell Death
10%
Hypoxia
10%
Cholecystokinin
10%
Medicine
9%
Gut
9%
Ob/Ob Mouse
8%
Insulin Dependent Diabetes Mellitus
8%
Side Effect
8%
Insulin Sensitivity
8%
Cancer Therapy
8%
Rose Bengal
7%
Messenger RNA
7%
Cell Proliferation
7%
Receptor Antagonist
7%
Alzheimer's Disease
7%
Biological Activity
7%
Cell Signaling Pathway
7%
Hydrocortisone
7%
Sitagliptin
7%
Food Intake
7%
Oxyntomodulin
7%
Antibiotics
7%
Gastrin
6%
Glycon
6%
Photosensitizer
6%
Biological Marker
6%
Prevalence
6%
Reactive Oxygen Species
6%
Pancreas Polypeptide
6%
Glucose Homeostasis
6%
Oxidative Stress
6%
Drug Therapy
6%
Caloric Intake
6%
Cardiovascular Disease
6%
Liraglutide
6%
Physical Activity Level
6%
Glucagon Like Peptide 2
6%
Clinical Trial
5%
Blood Glucose
5%
Cancer Cell
5%
Aminolevulinic Acid
5%
Peptide YY
5%
Health Care
5%
Vasopressin V1a Receptor
5%
Vasopressin V1b Receptor
5%
Hyperglycemia
5%
Sensitization
5%
Antibiotic Resistance
5%
Protein Variant
5%
Conjugate
5%
Breast Cancer
5%
Systematic Review
5%
Volunteer
5%
Amino Acid
5%
Diet Induced Obesity
5%
Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
69%
Insulin Release
33%
Glucagon
29%
Glucagon-Like Peptide-1
24%
Receptor Antagonist
21%
Glucose Homeostasis
20%
Glucagon Receptor
19%
Gastric Inhibitory Polypeptide Receptor
18%
SARS Coronavirus
18%
Cell Function
17%
Glucagon-Like Peptide 1 Receptor
14%
Body Weight
14%
Antidiabetic Activity
14%
Agonist
13%
Streptozotocin
13%
Ob/Ob Mouse
13%
Programmed Cell Death
12%
Cell Survival
11%
Glucose Blood Level
11%
Cancer Cell
11%
Prevalence
10%
Insulin Sensitivity
10%
Cholecystokinin
10%
Incretin
9%
Satiety
9%
Microbubble
9%
Blood Plasma
9%
Enteroglucagon
9%
Amino Acids
8%
Kluyveromyces marxianus
8%
Oxygenase
8%
Photodynamics
8%
Receptor Agonists
8%
Enzyme
8%
Cross Sectional Study
8%
Transdifferentiation
7%
Insulin Resistance
7%
Peptide YY
7%
Gene Expression
7%
Anticancer
7%
Gene Therapy
6%
Lactose
6%
Solution and Solubility
6%
N-Terminus
6%
Metabolic Regulation
6%
C-Terminus
6%
Biological Activity
5%
Animal Model
5%
Metabolic Pathway
5%
Hypoxia-Inducible Factors
5%
Bone Strength
5%
Neuropeptide
5%
Procollagen-Proline Dioxygenase
5%
Bone Mass
5%
Open Reading Frame
5%
Glucagon Release
5%
MicroRNA
5%
Pancreatic Polypeptide
5%
GTPase
5%
Insulin Blood Level
5%
Lipid
5%